US 12049464
Compounds for targeted degradation of BRD9
granted A61KA61K45/06A61P
Quick answer
US patent 12049464 (Compounds for targeted degradation of BRD9) held by C4 THERAPEUTICS, INC. expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00